BSECompany Update9h ago · 29 Jul 2026, 10:18 am
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nuvama Crossover Opportunities Fund ....
Sudeep Pharma Ltd · 544619
✦ AI SummaryRegulatory
Sudeep Pharma Ltd has received a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Nuvama Crossover Opportunities Fund regarding a potential acquisition of shares.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sudeep Pharma Ltd - 544619 - Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011